| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Edmond Mesrobian is Director at CRTO. Edmond Mesrobian's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $481K at current prices.
Net of sales, the CRTO filings show accumulation of 495 shares.
Edmond Mesrobian has 10 Form 4 filings on record from March 2017 to July 2026, all as Director at Criteo (CRTO), 2017–2026.
The 12 reported transactions were 7 stock awards, 3 option or other derivative awards, 1 disposition back to the company and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $12K and no sales.
The only open-market purchase was 495 shares of CRTO at an average $23.86 on November 7, 2022, about $12K. Twelve months later CRTO was up 2%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | CRTO Criteo S.A. | Director | Buy | 495 | $23.86 | $11,809.96 | +3.1% | +32.2% | +1.8% |